• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌和上尿路尿路上皮癌的外科治疗。

Surgery for Bladder and Upper Tract Urothelial Cancer.

机构信息

Nanavati Super-Specialty Hospital, S.V Road, Vile Parle West, Mumbai 400056, India; Department of Urology, University of Miami Miller School of Medicine.

Department of Urology, Member Sylvester Cancer Center, University of Miami Miller School of Medicine, University of Miami Health System, 1120 Northwest 14th Street, Suite 1560B, Miami, FL 33136, USA.

出版信息

Hematol Oncol Clin North Am. 2021 Jun;35(3):543-566. doi: 10.1016/j.hoc.2021.02.005. Epub 2021 Apr 15.

DOI:10.1016/j.hoc.2021.02.005
PMID:33958150
Abstract

The cornerstone for diagnosis and treatment of bladder and upper tract urothelial carcinoma involves surgery. Transurethral resection of bladder tumors forms the basis of further management. Radical cystectomy for invasive bladder carcinoma provides good oncologic outcomes. However, it can be a morbid procedure, and advances such as minimally invasive surgery and early recovery after surgery need to be incorporated into routine practice. Diagnostic ureteroscopy for upper tract carcinoma is needed in cases of doubt after cytology and imaging studies. Low-risk cancers can be managed with conservative endoscopic surgery without compromising oncological outcomes; however, high-risk disease necessitates radical nephroureterectomy.

摘要

膀胱和上尿路尿路上皮癌的诊断和治疗的基石是手术。经尿道膀胱肿瘤切除术是进一步治疗的基础。浸润性膀胱癌的根治性膀胱切除术可获得良好的肿瘤学结果。然而,它可能是一种病态的手术,因此需要将微创技术和术后早期康复等进展纳入常规实践。在细胞学和影像学检查后仍有疑问的情况下,需要进行诊断性输尿管镜检查以明确上尿路癌。低危癌症可以通过保守的内镜手术进行治疗,而不会影响肿瘤学结果;然而,高危疾病需要根治性肾输尿管切除术。

相似文献

1
Surgery for Bladder and Upper Tract Urothelial Cancer.膀胱癌和上尿路尿路上皮癌的外科治疗。
Hematol Oncol Clin North Am. 2021 Jun;35(3):543-566. doi: 10.1016/j.hoc.2021.02.005. Epub 2021 Apr 15.
2
Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的临床意义。
Int J Urol. 2016 May;23(5):378-84. doi: 10.1111/iju.13054. Epub 2016 Jan 18.
3
Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.有膀胱尿路上皮癌病史患者的上尿路尿路上皮癌的内镜治疗
J Urol. 2007 May;177(5):1721-6. doi: 10.1016/j.juro.2007.01.006.
4
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.腹腔镜肾输尿管切除术与开放根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局:欧洲泌尿外科学会指南系统评价。
Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15.
5
Clinicopathological features and oncological outcomes of urothelial carcinoma involving the ureterovesical junction.累及输尿管膀胱连接部的尿路上皮癌的临床病理特征和肿瘤学结局。
Jpn J Clin Oncol. 2022 Jan 3;52(1):65-72. doi: 10.1093/jjco/hyab143.
6
Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后既往、同期或随后膀胱癌对预后的影响。
J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.
7
Robotic nephroureterectomy in the management of upper tract urothelial cancer: inching toward standard of care?机器人辅助肾盂输尿管癌根治术在治疗上尿路尿路上皮癌中的应用:是否逐渐成为标准治疗方法?
Int Urol Nephrol. 2022 Aug;54(8):1777-1785. doi: 10.1007/s11255-022-03225-1. Epub 2022 May 24.
8
Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.机器人辅助与开放性根治性肾输尿管切除术治疗上尿路上皮癌:跨越十年的回顾性队列研究。
Surg Oncol. 2021 Sep;38:101607. doi: 10.1016/j.suronc.2021.101607. Epub 2021 May 16.
9
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.保留肾单位的输尿管切除术与根治性肾输尿管切除术治疗上尿路上皮癌的肾功能和肿瘤学结局。
J Urol. 2012 Feb;187(2):429-34. doi: 10.1016/j.juro.2011.09.150. Epub 2011 Dec 15.
10
Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.膀胱癌治疗后上尿路复发:监测与管理的综述。
Curr Opin Urol. 2019 May;29(3):189-197. doi: 10.1097/MOU.0000000000000598.

引用本文的文献

1
A case of bladder urothelial carcinoma nested variant with invasion to the rectum treated with surgery and intraoperative radiotherapy.1例膀胱尿路上皮癌巢状变异型侵及直肠患者接受手术及术中放疗治疗。
Quant Imaging Med Surg. 2023 Aug 1;13(8):5409-5416. doi: 10.21037/qims-23-67. Epub 2023 Jun 29.
2
Updates on the Pivotal Roles of Mitochondria in Urothelial Carcinoma.线粒体在尿路上皮癌中的关键作用的最新进展
Biomedicines. 2022 Oct 1;10(10):2453. doi: 10.3390/biomedicines10102453.
3
5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer.
5-甲基胞嘧啶相关长非编码 RNA 是预测膀胱癌患者总生存期和调节肿瘤免疫微环境的潜在生物标志物。
Dis Markers. 2022 Mar 4;2022:3117359. doi: 10.1155/2022/3117359. eCollection 2022.